edaravone has been researched along with Mesenteric Vascular Occlusion in 2 studies
Mesenteric Vascular Occlusion: Obstruction of the flow in the SPLANCHNIC CIRCULATION by ATHEROSCLEROSIS; EMBOLISM; THROMBOSIS; STENOSIS; TRAUMA; and compression or intrinsic pressure from adjacent tumors. Rare causes are drugs, intestinal parasites, and vascular immunoinflammatory diseases such as PERIARTERITIS NODOSA and THROMBOANGIITIS OBLITERANS. (From Juergens et al., Peripheral Vascular Diseases, 5th ed, pp295-6)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To increase the survival rate of patients with acute superior mesenteric artery thromboembolism (ASMAT) treated by catheter thrombolysis, we examined the effects of delivering edaravone and asialoerythropoietin, agents with tissue-protective activities, using a rabbit autologous fibrin clot ASMAT model." | 7.76 | Does the concomitant intra-arterial injection of asialoerythropoietin and edaravone mitigate ischaemic mucosal damage after acute superior mesenteric artery thromboembolism in a rabbit autologous fibrin clot model? ( Kashiwagi, A; Murata, K; Nitta, N; Ohta, S; Seko, A; Sonoda, A; Sugimoto, T; Takahashi, M; Takemura, S; Uzu, T; Yokomaku, Y, 2010) |
| "The aim of this study was to evaluate the effects of intra-arterial administration of edaravone after superior mesenteric artery (SMA) thromboembolism in a rabbit model." | 7.75 | Edaravone prevents bowel infarction after acute superior mesenteric artery thromboembolism using autologous fibrin clots in a rabbit model. ( Miyagawa, Y; Murata, K; Nitta, N; Ohta, S; Seko, A; Sonoda, A; Takahashi, M; Takemura, S, 2009) |
| "To increase the survival rate of patients with acute superior mesenteric artery thromboembolism (ASMAT) treated by catheter thrombolysis, we examined the effects of delivering edaravone and asialoerythropoietin, agents with tissue-protective activities, using a rabbit autologous fibrin clot ASMAT model." | 3.76 | Does the concomitant intra-arterial injection of asialoerythropoietin and edaravone mitigate ischaemic mucosal damage after acute superior mesenteric artery thromboembolism in a rabbit autologous fibrin clot model? ( Kashiwagi, A; Murata, K; Nitta, N; Ohta, S; Seko, A; Sonoda, A; Sugimoto, T; Takahashi, M; Takemura, S; Uzu, T; Yokomaku, Y, 2010) |
| "The aim of this study was to evaluate the effects of intra-arterial administration of edaravone after superior mesenteric artery (SMA) thromboembolism in a rabbit model." | 3.75 | Edaravone prevents bowel infarction after acute superior mesenteric artery thromboembolism using autologous fibrin clots in a rabbit model. ( Miyagawa, Y; Murata, K; Nitta, N; Ohta, S; Seko, A; Sonoda, A; Takahashi, M; Takemura, S, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sonoda, A | 2 |
| Nitta, N | 2 |
| Seko, A | 2 |
| Ohta, S | 2 |
| Takemura, S | 2 |
| Miyagawa, Y | 1 |
| Takahashi, M | 2 |
| Murata, K | 2 |
| Sugimoto, T | 1 |
| Uzu, T | 1 |
| Yokomaku, Y | 1 |
| Kashiwagi, A | 1 |
2 other studies available for edaravone and Mesenteric Vascular Occlusion
| Article | Year |
|---|---|
Edaravone prevents bowel infarction after acute superior mesenteric artery thromboembolism using autologous fibrin clots in a rabbit model.
Topics: Animals; Anticoagulants; Antipyrine; Case-Control Studies; Disease Models, Animal; Edaravone; Fibrin | 2009 |
Does the concomitant intra-arterial injection of asialoerythropoietin and edaravone mitigate ischaemic mucosal damage after acute superior mesenteric artery thromboembolism in a rabbit autologous fibrin clot model?
Topics: Animals; Antipyrine; Asialoglycoproteins; Catheterization; Disease Models, Animal; Drug Combinations | 2010 |